Patents by Inventor Donald Awrey

Donald Awrey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel purified polypeptides from Staphylococcus aureus
    Publication number: 20060258845
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: January 11, 2006
    Publication date: November 16, 2006
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Donald Awrey, Teresa McGrath, Vladimir Romanov
  • Novel purified polypeptides from bacteria
    Publication number: 20050181388
    Abstract: The present invention relates to polypeptide targets for pathogenic bacteria. The invention also provides biochemical and biophysical characteristics of those polypeptides.
    Type: Application
    Filed: October 4, 2004
    Publication date: August 18, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Muhammad Alam, Cheryl Arrowsmith, Donald Awrey, Bryan Beattie, Kristina Buzadzija, Veronica Canadien, Megan Domagala, Simon Houston, Dhushy Kanagarajah, Qin Li, Kamran Mansoury, Merry-Lynn McDonald, Kathleen Nethery-Brokx, Ivy Ng, Hui Ouyang, Benjamin Pinder, Dawn Richards, Matthew Tai, Rosanne Thalakada, Francois Vallee, Cristina Virag
  • Novel purified polypeptides from bacteria
    Publication number: 20050181464
    Abstract: The present invention relates to polypeptide targets for pathogenic bacteria. The invention also provides biochemical and biophysical characteristics of those polypeptides.
    Type: Application
    Filed: September 29, 2004
    Publication date: August 18, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Muhammad Alam, Cheryl Arrowsmith, Donald Awrey, Bryan Beattie, Kristina Buzadzija, Teresa Clarke, Megan Domagala, Simon Houston, Dhushy Kanagarajah, Qin Li, Kamran Mansoury, Merry-Lynn McDonald, Kathleen Nethery-Brokx, Ivy Ng, Hui Ouyang, Dawn Richards, Francois Vallee, Cristina Virag
  • Novel purified polypeptides from pseudomonas aeruginosa
    Publication number: 20050164362
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: June 21, 2004
    Publication date: July 28, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Muhammad Alam, Megan Domagala, Simon Houston, Matthew Kimber, Benjamin Pinder, Francois Vallee, Olga Wrezel, Donald Awrey, Bryan Beattie
  • Cell cultures
    Publication number: 20040121445
    Abstract: Disclosed herein are methods, media and other compositions relating to high density cell cultures. Also disclosed are exemplary methods for using high density cell cultures and exemplary products that may be obtained from high density cell cultures.
    Type: Application
    Filed: July 30, 2003
    Publication date: June 24, 2004
    Inventors: Fabien Marino, Aled Edwards, Akil Dharamsi, Donald Awrey
  • Methods and apparatuses for purification
    Publication number: 20030170810
    Abstract: Proteins can be purified and concentrated from crude cell lysates using high-throughput, automated process control systems that use software application programs to instruct one or more processors, controllers, and actuators to control and/or monitor the operations of filtration, purification, and concentration modules in such systems. The high-throughput production of concentrated proteins can be enabled by filtering the lysates and using compressed, non-reactive gas to concentrate the purified proteins, rather than using more complex centrifugation techniques.
    Type: Application
    Filed: September 18, 2002
    Publication date: September 11, 2003
    Inventors: Masoud Vedadi, Donald Awrey, Aled Edwards, Fabien Marino, Matt Narrol, Hai Luong, Raymond Hui
  • Methods for gene disruption and uses thereof
    Publication number: 20030082591
    Abstract: The present invention relates to compositions and methods for in-frame disruption of a gene sequence by homologous recombination. The present invention may be used in certain embodiments to disrupt a gene without causing any downstream effects on non-target sequences. In certain embodiments, the inventive methods may be used to identify and/or characterize products encoded by essential genes, conditionally essential genes, and non-essential genes.
    Type: Application
    Filed: July 24, 2002
    Publication date: May 1, 2003
    Inventors: Donald Awrey, Jack Greenblatt